Diconal

Diconal is a brand name for dipipanone hydrochloride, a synthetic opioid analgesic. It was developed in the United Kingdom in the 1950s and was prescribed for the management of moderate to severe pain. Diconal is a Schedule II controlled substance in the United States and is similarly controlled in many other countries due to its potential for abuse and dependence.

The pharmacological action of dipipanone is primarily as an agonist at mu-opioid receptors, similar to other opioid analgesics. It is effective in relieving pain but also carries the risk of side effects common to opioids, including constipation, nausea, vomiting, drowsiness, and respiratory depression. Due to its potency and the risk of addiction, Diconal was typically prescribed for short-term use or for patients with severe, intractable pain under close medical supervision.

In some regions, Diconal was also known to be misused or diverted for recreational purposes, leading to concerns about public health and safety. Regulatory bodies have increasingly tightened controls on its availability and prescription. As newer and potentially safer analgesic options have become available, the use of Diconal has declined in many parts of the world. Its availability and prescription status vary significantly by country.